JCRB1003 Kasumi-1
Cell information
Important Notice(s)On the particles appear in cultures of Kasumi-series cell lines
Surface antigen expressions in Kasumi-1 cells.
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1003 | Cell Name | Kasumi-1 |
---|---|---|---|
Profile | A novel leukemia cell line with an t8;21 chromosome translocation established from a patient attaked by acute myeloid leukemia(AML). | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 7 |
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | aculte myeloid leukemia (AML). | Metastasis | |
Tissue Metastasized | Genetics | t(8:21), AML-ETO fusion gene | |
Life Span | infinite | Crisis PDL | |
Morphology | myeloblast | Character | MPO+, CD34+, CD13+ |
Classify | tumor | Established by | Asou,H. |
Registered by | Kyoizumi,S. &Asou,H. | Regulation for Distribution | free |
Comment | Year | 2000 | |
Medium | RPMI1640 medium with 10% heat inactivated fetal calf serum. | Methods for Passages | Subculture twice a week at split ratio of 1/2 -1/3 by simple dilution. Suspension cell culture. |
Cell Number on Passage | Split ratio = 1/2-1/3. | Race | Japanese |
CO2 Conc. | 5 % | Tissue Sampling | blood |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:11283671 | AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Pabst T,Mueller BU,Harakawa N,Schoch C,Haferlach T,Behre G,Hiddemann W,Zhang DE,Tenen DG Nat Med. 2001 Apr;7(4):444-51 |
Pubmed id:8334990 | The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. Miyoshi H,Kozu T,Shimizu K,Enomoto K,Maseki N,Kaneko Y,Kamada N,Ohki M EMBO J. 1993 Jul;12(7):2715-21 |
Pubmed id:1720541 | t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Miyoshi H,Shimizu K,Kozu T,Maseki N,Kaneko Y,Ohki M Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10431-4 |
Pubmed id:2018839 | Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Asou H,Tashiro S,Hamamoto K,Otsuji A,Kita K,Kamada N Blood. 1991 May 1;77(9):2031-6 |
Research results by users. Click! | |
---|---|
Pubmed id:32180206 |
Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations. Kasai F,Asou H,Ozawa M,Kobayashi K,Kuramitsu H,Satoh M,Kohara A,Kaneko Y,Kawamura M Hum Cell. 2020 Jul;33(3):868-876 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | JCRB1003 | Cell Name | Kasumi-1 |
---|---|---|---|
LOT No. | 03232010 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% heat-inactivated fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 4 - 10 x 10^4 cells/ml | Methods for Passages | Simple dilution (suspension culture) |
Doubling Time | approx. 4-5 days. | Cell Number in Vial (cells/1ml) | 7.3 x 10^5 |
Viability at cell freezing (%) | 89.1 | Antibiotics Used | free |
Passage Number | Unknown (8 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information | On vial: lot number is mis-labeled as 01023230, correctly 03232010. |
Cell No. | JCRB1003 | Cell Name | |
---|---|---|---|
LOT No. | 02262002 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% heat inactivated fetal calf serum. (Use 20% serum at thawing) | Temperature | 37 C |
Cell Density at Seeding | Split ratio = 1/2-1/3. | Methods for Passages | Subculture twice a week at split ratio of 1/2 -1/3 by simple dilution. Suspension cell culture. |
Doubling Time | Cell Number in Vial (cells/1ml) | >10^6 | |
Viability at cell freezing (%) | NT | Antibiotics Used | fee |
Passage Number | PDL | ||
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 5% DMSO-Culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1003 | Cell Name | Kasumi-1 |
---|---|---|---|
LOT No. | 09032015 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% heat-inactivated fetal bovine serum (FBS; GIBCO Cat. # 10091). | Temperature | 37 C |
Cell Density at Seeding | 3.1 - 4.9 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture), split ratio of 1/2 -1/3 is recommended. |
Doubling Time | approx. 3 days | Cell Number in Vial (cells/1ml) | 2.4 x 10^6 |
Viability at cell freezing (%) | 72.2 | Antibiotics Used | free |
Passage Number | Unknown (8 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% heat-inactivated FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 72.2 | Additional information |
Cell No. | JCRB1003 | Cell Name | Kasumi-1 |
---|---|---|---|
LOT No. | 02092018 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA12J396) | Temperature | 37 C |
Cell Density at Seeding | 2.8-5.2x10^5 cells/sq.cm | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.0x10^6 |
Viability at cell freezing (%) | 97.40 | Antibiotics Used | free |
Passage Number | p8* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | NT | Additional information | Start culture under 2 ml growth medium,because cell number is under 1.0x10^6 cells/vial. |
Images |
---|
Cell No. | JCRB1003 | Cell Name | Kasumi-1 |
---|---|---|---|
LOT No. | 05112018 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA12J396) | Temperature | 37 C |
Cell Density at Seeding | 3.0-4.3x10^5 cells/sq.cm | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.8x10^6 |
Viability at cell freezing (%) | 97.10 | Antibiotics Used | free |
Passage Number | p8* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9,11 D13S317:11,13 D7S820:8,11 D16S539:9,12 VWA:14 TH01:6,9 AM:X TPOX:8,9 CSF1PO:10,12 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 80 | Additional information |
Images |
---|
Cell No. | JCRB1003 | Cell Name | Kasumi-1 |
---|---|---|---|
LOT No. | 07252022 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10437) | Temperature | 37 C |
Cell Density at Seeding | approx. 6 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture) |
Doubling Time | 54 - 95 hrs. | Cell Number in Vial (cells/1ml) | 1.6 x 10^6 |
Viability at cell freezing (%) | 80.2 | Antibiotics Used | free |
Passage Number | Unknown (8 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:9,11 D13S317:11,13 D7S820:8,11 D16S539:9,12 VWA:14 TH01:6,9 AM:X TPOX:8,9 CSF1PO:10,12 |
|
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 80.0 | Additional information |